Logo image of 9MW.DE

MARVELL TECHNOLOGY INC (9MW.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:9MW - US5738741041 - Common Stock

71.03 EUR
+4.09 (+6.11%)
Last: 11/25/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, 9MW scores 3 out of 10 in our fundamental rating. 9MW was compared to 60 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of 9MW is average, but there are quite some concerns on its profitability. 9MW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

9MW had positive earnings in the past year.
9MW had a positive operating cash flow in the past year.
In the past 5 years 9MW reported 4 times negative net income.
9MW had a positive operating cash flow in each of the past 5 years.
9MW.DE Yearly Net Income VS EBIT VS OCF VS FCF9MW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

1.2 Ratios

The Return On Assets of 9MW (-1.74%) is worse than 80.00% of its industry peers.
With a Return On Equity value of -2.46%, 9MW is not doing good in the industry: 78.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.74%
ROE -2.46%
ROIC N/A
ROA(3y)-1.74%
ROA(5y)1.45%
ROE(3y)-2.34%
ROE(5y)1.76%
ROIC(3y)N/A
ROIC(5y)N/A
9MW.DE Yearly ROA, ROE, ROIC9MW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

9MW's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 45.01%, 9MW is in line with its industry, outperforming 55.00% of the companies in the same industry.
9MW's Gross Margin has declined in the last couple of years.
9MW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.01%
OM growth 3YN/A
OM growth 5Y-17.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.13%
GM growth 5Y-3.62%
9MW.DE Yearly Profit, Operating, Gross Margins9MW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

9MW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 9MW has more shares outstanding
Compared to 5 years ago, 9MW has more shares outstanding
Compared to 1 year ago, 9MW has an improved debt to assets ratio.
9MW.DE Yearly Shares Outstanding9MW.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
9MW.DE Yearly Total Debt VS Total Assets9MW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

9MW has an Altman-Z score of 6.92. This indicates that 9MW is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.92, 9MW is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
9MW has a debt to FCF ratio of 5.42. This is a neutral value as 9MW would need 5.42 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.42, 9MW is in line with its industry, outperforming 50.00% of the companies in the same industry.
9MW has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
9MW has a Debt to Equity ratio of 0.20. This is in the better half of the industry: 9MW outperforms 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.42
Altman-Z 6.92
ROIC/WACCN/A
WACC10.36%
9MW.DE Yearly LT Debt VS Equity VS FCF9MW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

9MW has a Current Ratio of 1.03. This is a normal value and indicates that 9MW is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 9MW (1.03) is worse than 83.33% of its industry peers.
9MW has a Quick Ratio of 1.03. This is a bad value and indicates that 9MW is not financially healthy enough and could expect problems in meeting its short term obligations.
9MW has a worse Quick ratio (0.65) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.65
9MW.DE Yearly Current Assets VS Current Liabilites9MW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for 9MW have decreased strongly by -17.33% in the last year.
9MW shows a small growth in Revenue. In the last year, the Revenue has grown by 1.82%.
9MW shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.70% yearly.
EPS 1Y (TTM)-17.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
Revenue 1Y (TTM)1.82%
Revenue growth 3Y29.92%
Revenue growth 5Y19.7%
Sales Q2Q%-11.6%

3.2 Future

9MW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.45% yearly.
The Revenue is expected to grow by 13.32% on average over the next years. This is quite good.
EPS Next Y-2.3%
EPS Next 2Y16.69%
EPS Next 3Y10.55%
EPS Next 5Y17.45%
Revenue Next Year2.24%
Revenue Next 2Y11.21%
Revenue Next 3Y7.83%
Revenue Next 5Y13.32%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
9MW.DE Yearly Revenue VS Estimates9MW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
9MW.DE Yearly EPS VS Estimates9MW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 48.99, which means the current valuation is very expensive for 9MW.
Based on the Price/Earnings ratio, 9MW is valued a bit more expensive than 61.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of 9MW to the average of the S&P500 Index (26.15), we can say 9MW is valued expensively.
9MW is valuated quite expensively with a Price/Forward Earnings ratio of 27.79.
The rest of the industry has a similar Price/Forward Earnings ratio as 9MW.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, 9MW is valued a bit cheaper.
Industry RankSector Rank
PE 48.99
Fwd PE 27.79
9MW.DE Price Earnings VS Forward Price Earnings9MW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 9MW is valued expensively inside the industry as 81.67% of the companies are valued cheaper.
9MW's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 92.43
EV/EBITDA 59.14
9MW.DE Per share data9MW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.69%
EPS Next 3Y10.55%

0

5. Dividend

5.1 Amount

9MW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARVELL TECHNOLOGY INC

FRA:9MW (11/25/2025, 7:00:00 PM)

71.03

+4.09 (+6.11%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.28B
Revenue(TTM)5.62B
Net Income(TTM)-378.50M
Analysts83.24
Price Target66.61 (-6.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-54.29%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.99%
Min EPS beat(2)0.28%
Max EPS beat(2)3.7%
EPS beat(4)2
Avg EPS beat(4)-1.11%
Min EPS beat(4)-4.76%
Max EPS beat(4)3.7%
EPS beat(8)4
Avg EPS beat(8)0.63%
EPS beat(12)6
Avg EPS beat(12)0.98%
EPS beat(16)9
Avg EPS beat(16)2.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-1.04%
Max Revenue beat(2)-0.32%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-3.13%
Max Revenue beat(4)-0.32%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)2
Avg Revenue beat(12)-0.79%
Revenue beat(16)3
Avg Revenue beat(16)-0.92%
PT rev (1m)2.34%
PT rev (3m)3.77%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)0.6%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 48.99
Fwd PE 27.79
P/S 12.6
P/FCF 92.43
P/OCF 65.34
P/B 4.6
P/tB N/A
EV/EBITDA 59.14
EPS(TTM)1.45
EY2.04%
EPS(NY)2.56
Fwd EY3.6%
FCF(TTM)0.77
FCFY1.08%
OCF(TTM)1.09
OCFY1.53%
SpS5.64
BVpS15.44
TBVpS-1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.45
Profitability
Industry RankSector Rank
ROA -1.74%
ROE -2.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.01%
FCFM 13.63%
ROA(3y)-1.74%
ROA(5y)1.45%
ROE(3y)-2.34%
ROE(5y)1.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-17.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.13%
GM growth 5Y-3.62%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 5.42
Debt/EBITDA 2.5
Cap/Depr 22.82%
Cap/Sales 5.65%
Interest Coverage N/A
Cash Conversion 86.46%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.65
Altman-Z 6.92
F-Score4
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)16.42%
Cap/Depr(5y)18.85%
Cap/Sales(3y)3.96%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
EPS Next Y-2.3%
EPS Next 2Y16.69%
EPS Next 3Y10.55%
EPS Next 5Y17.45%
Revenue 1Y (TTM)1.82%
Revenue growth 3Y29.92%
Revenue growth 5Y19.7%
Sales Q2Q%-11.6%
Revenue Next Year2.24%
Revenue Next 2Y11.21%
Revenue Next 3Y7.83%
Revenue Next 5Y13.32%
EBIT growth 1Y-163.66%
EBIT growth 3YN/A
EBIT growth 5Y-1.47%
EBIT Next Year10.01%
EBIT Next 3Y15.75%
EBIT Next 5Y16.44%
FCF growth 1Y51.98%
FCF growth 3Y57.61%
FCF growth 5Y15.29%
OCF growth 1Y73.57%
OCF growth 3Y52.94%
OCF growth 5Y17.68%

MARVELL TECHNOLOGY INC / 9MW.DE FAQ

What is the fundamental rating for 9MW stock?

ChartMill assigns a fundamental rating of 3 / 10 to 9MW.DE.


What is the valuation status of MARVELL TECHNOLOGY INC (9MW.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to MARVELL TECHNOLOGY INC (9MW.DE). This can be considered as Overvalued.


Can you provide the profitability details for MARVELL TECHNOLOGY INC?

MARVELL TECHNOLOGY INC (9MW.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for 9MW stock?

The Earnings per Share (EPS) of MARVELL TECHNOLOGY INC (9MW.DE) is expected to decline by -2.3% in the next year.


How sustainable is the dividend of MARVELL TECHNOLOGY INC (9MW.DE) stock?

The dividend rating of MARVELL TECHNOLOGY INC (9MW.DE) is 0 / 10 and the dividend payout ratio is -54.29%.